{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04853251",
            "orgStudyIdInfo": {
                "id": "ML43000"
            },
            "organization": {
                "fullName": "Genentech, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study Assessing Corneal Endothelial Cells in Patients With Neovascular Age-related Macular Degeneration Treated With the Port Delivery System With Ranibizumab (PDS)",
            "officialTitle": "A PHASE IV, MULTICENTER, OPEN-LABEL STUDY TO ASSESS CORNEAL ENDOTHELIAL CELLS IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH THE PORT DELIVERY SYSTEM WITH RANIBIZUMAB (PDS)",
            "acronym": "Belvedere",
            "therapeuticArea": [
                "Ophthalmology"
            ],
            "study": "a-study-assessing-corneal-endothelial-cells-in-patients-with-neovascular-age-related-macular-degeneration-treated-with-the-port-delivery-system-with-ranibizumab-pds"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-12-14",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-04-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-04-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-04-16",
            "studyFirstSubmitQcDate": "2021-04-16",
            "studyFirstPostDateStruct": {
                "date": "2021-04-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-16",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-18",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Genentech, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "This study will assess corneal endothelial cells in patients with neovascular age-related macular degeneration (nAMD) treated with Port Delivery System with ranibizumab (PDS) refilled every 24 weeks (Q24W)"
        },
        "conditionsModule": {
            "conditions": [
                "Neovascular Age-related Macular Degeneration"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 185,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "SUSVIMO",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will have the implant (filled prior to implantation with approximately 20 uL of the 100-mg/mL formulation of ranibizumab \\[approximately 2-mg dose of ranibizumab\\]) surgically inserted in the study eye at the Day 1 visit following their enrollment visit. After the initial fill of the implant with ranibizumab, patients will receive implant refill-exchanges at fixed 24-week intervals.",
                    "interventionNames": [
                        "Device: SUSVIMO Port Delivery System with ranibizumab (PDS)",
                        "Drug: LUCENTIS (ranibizumab injection)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "SUSVIMO Port Delivery System with ranibizumab (PDS)",
                    "description": "The ranibizumab 100 mg/mL will be delivered via the Port Delivery System",
                    "armGroupLabels": [
                        "SUSVIMO"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "LUCENTIS (ranibizumab injection)",
                    "description": "Ranibizumab (intravitreal 0.5-mg intravitreal injections of 10 mg/mL formulation) will be used in the study eye as supplemental treatment. If a study patient discontinues study treatment, he/she may start receiving intravitreal ranibizumab injections in the study eye, per investigator's discretion.",
                    "armGroupLabels": [
                        "SUSVIMO"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percent change in corneal ECD from baseline at Week 48 in the study eye as compared with the fellow eye, as assessed by specular microscopy",
                    "timeFrame": "Baseline up to Week 48"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Percent change in corneal ECD from baseline at Week 24 in the study eye as compared with the fellow eye",
                    "timeFrame": "Baseline up to Week 24"
                },
                {
                    "measure": "Percent change in the CV of corneal endothelial cell area (standard deviation of the cell area/mean cell area) from baseline at Weeks 24 and 48 in the study eye as compared with the fellow eye",
                    "timeFrame": "Baseline, Week 24, Week 48"
                },
                {
                    "measure": "Percent change in HEX from baseline at Weeks 24 and 48 in the study eye as compared with the fellow eye",
                    "timeFrame": "Baseline, Week 24, Week 48"
                },
                {
                    "measure": "Percentage of participants with ocular serious adverse events (SAEs)",
                    "timeFrame": "Day 1 up to approximately Week 52"
                },
                {
                    "measure": "Percentage of participants with ocular adverse events of special interest (AESIs)",
                    "timeFrame": "Day 1 to Week 52"
                },
                {
                    "measure": "Percentage of participants with adverse device effects (ADEs) in the course of the study",
                    "timeFrame": "Day 1 to Week 52"
                },
                {
                    "measure": "Percentage of participants with ocular AESIs during the postoperative period",
                    "timeFrame": "Baseline up to 37 days of initial implantation"
                },
                {
                    "measure": "Percentage of participants with ocular AESIs during the intermediate postoperative period",
                    "timeFrame": "38 to 93 days after implantation"
                },
                {
                    "measure": "Percentage of participants with ocular AESIs during the follow-up period",
                    "description": "The investigator will follow each adverse event until the event has resolved to baseline grade or better, the event is assessed as stable by the investigator, the patient is lost to follow-up, or the patient withdraws consent.",
                    "timeFrame": "Week 52"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria\n\nOcular Inclusion Criteria\n\n* Initial diagnosis of nAMD within 18 months prior to screening\n* Difference of \\<10% in ECD at screening between the 2 eyes as measured by specular microscopy and determined by the independent reading center\n* Availability of historical visual acuity data and SD-OCT imaging prior to the first anti-VEGF IVT treatment for nAMD\n* Availability of comprehensive historical anti-VEGF injection data including anti-VEGF agent administered and date of administration from the first anti-VEGF treatment for nAMD\n* Demonstrated response to at least two anti-VEGF intravitreal injections since diagnosis\n* BCVA of 34 letters (approximate 20/200 Snellen equivalent) or better, using ETDRS chart at a starting distance of 4 meters at screening and enrollment\n* All subtypes of nAMD lesions are permissible\n* nAMD lesions at the time of diagnosis must involve the macula (6 mm diameter centered at the fovea)\n* Sufficiently clear ocular media and adequate pupillary dilation to allow for clinical examination and analysis and grading by the central reading center of SD-OCT images\n\nExclusion Criteria\n\nPrior Ocular Treatment Study Eye\n\n* Prior treatment with verteporfin for injection, external-beam radiation therapy, or transpupillary thermotherapy\n* Previous treatment with corticosteroid intravitreal injection\n* Previous laser (any type) used for AMD treatment\n* History of vitreous hemorrhage\n* History of rhegmatogenous retinal detachment\n* History of corneal transplant\n* History of conjunctival surgery in the superotemporal quadrant\n* History of conjunctival surgery in the superotemporal quadrant\n* Prior participation in a clinical trial involving any intravitreal anti-VEGF agents\n* Prior participation in a clinical trial involving any intravitreal anti-VEGF agents\n\nEither Eye\n\n* Previous PDS implantation\n* Previous intraocular surgery (including cataract surgery) within 6 months of study enrollment\n* Prior pars plana vitrectomy surgery\n* Previous intraocular device implantation excluding intraocular lenses\n* History of glaucoma-filtering surgery, tube shunts, or microinvasive glaucoma surgery\n* Intraocular laser therapy including selective laser trabeculoplasty, yttrium-aluminum garnet (YAG), prophylactic peripheral iridotomy within 1 year of screening, or YAG capsulotomy within 3 months of screening\n* Contact lens wear in either eye within 2 months of screening\n* Any prior ocular trauma (blunt or penetrating)\n* History of corneal transplantation, including partial-thickness corneal grafts\n* Prior treatment with brolucizumab\n* Prior treatment with any anti-VEGF biosimilar agents\n* Prior treatment with faricimab within 2 months of screening\n* Prior treatment with aflibercept 8 mg within 2 months of screening\n* Prior treatment with external-beam radiation therapy or brachytherapy\n\nMacular Neovascularization Lesion Characteristics\n\nStudy Eye\n\n* Subretinal hemorrhage that involves the center of the fovea, if the hemorrhage is greater than 0.5-disc area (1.27 mm2) in size at screening\n* Subfoveal fibrosis or subfoveal atrophy\n\nEither Eye\n\n* Aphakia or absence of the posterior capsule\n* Any concurrent intraocular condition that would either require surgical intervention during the study to prevent or treat visual loss that might result from that condition or affect interpretation of study results\n* Corneal ECD \u22641500 cells/mm2 in either eye at screening as determined by the independent reading center\n* Fuchs endothelial corneal dystrophy Grade \u2265 2\n* Previous corneal endothelial cell damage, including from blunt or surgical trauma\n* Any ocular condition that precludes obtaining an analyzable specular microscopy image\n* Active or history of corneal edema\n* Active or history of corneal dystrophies\n* Active or history of iridocorneal endothelial syndrome\n* Active or history of pseudoexfoliation syndrome\n* Active or history of herpetic keratitis or kerato-uveitis\n* Any active or history of uveitis\n* Active or history of keratitis, scleritis, or endophthalmitis\n* Active ocular or periocular infection\n* Active or history of Sjogren's syndrome or keratoconjunctivitis sicca\n* Active or history of floppy eyelid syndrome\n* Active or history of chronic eye rubbing\n* Active thyroid eye disease\n\nConcurrent Ocular Conditions Study Eye\n\n* Retinal pigment epithelial tear\n* Any concurrent intraocular condition (e.g., cataract, glaucoma, diabetic retinopathy, or epiretinal membrane) that would either require surgical intervention during the study to prevent or treat visual loss that might result from that condition or affect interpretation of study results\n* Retinal tears or peripheral retinal breaks on depressed fundus exam that are untreated, or treated within the 3 months prior to study enrollment\n* Aphakia or absence of the posterior capsule\n* Previous violation of the posterior capsule is also an exclusion criterion unless it occurred as a result of yttrium-aluminum garnet (YAG) laser posterior capsulotomy in association with prior, posterior chamber intraocular lens implantation\n* Spherical equivalent of the refractive error demonstrating more than 8 diopters of myopia or evidence of pathologic myopia on depressed fundus exam\n* Preoperative refractive error that exceeds 8 diopters of myopia, for patients who have undergone prior refractive or cataract surgery\n* Spherical equivalent of the refractive error demonstrating more than 5 diopters of hyperopia\n* Preoperative refractive error that exceeds 5 diopters of hyperopia, for patients who have undergone prior refractive or cataract surgery\n* Uncontrolled ocular hypertension or glaucoma\n* Scleral pathology in the superotemporal quadrant (e.g., scleral thinning or calcification)\n* Conjunctival pathologies in the superotemporal quadrant\n* History or presence of severe posterior blepharitis, recurrent chalazia or hordeolum, severe dry eye syndrome, or severe allergic conjunctivitis\n* Ectropion, entropion or other impairment of the upper or lower eyelid impacting lid functionality needed to protect the ocular surface from exposure\n* Trichiasis\n* Corneal neuropathy\n* Lagophthalmos or incomplete blink\n* Active or history of facial nerve palsy/paresis\n\nFellow (Non-Study) Eye\n\n\u2022 Concurrent PDS implantation\n\nConcurrent Systemic Conditions\n\n* Uncontrolled blood pressure\n* Active or history of autoimmune diseases such as rheumatoid arthritis, lupus, granulomatosis with polyangiitis (Wegner's), etc.\n* History of stroke within the last 3 months prior to screening\n* Uncontrolled atrial fibrillation within 3 months of screening\n* History of myocardial infarction within the last 3 months prior to screening\n* History of other disease, metabolic dysfunction, or clinical laboratory finding giving reasonable suspicion of a disease or condition that contraindicates the use of ranibizumab or placement of the implant and that might affect interpretation of the results of the study or renders the patient at high risk of treatment complications, in the opinion of the investigator\n* Current active systemic infection\n* Use of any systemic anti-VEGF agents\n* Chronic use of oral corticosteroids\n* Active cancer within 12 months of enrollment except for appropriately treated carcinoma in situ of the cervix, non-melanoma skin carcinoma, and prostate cancer with a Gleason score of \u2264 6 and a stable prostate-specific antigen for \\> 12 months\n* Previous participation in any non-ocular (systemic) disease studies of investigational drugs within 1 month prior to screening (excluding vitamins and minerals)\n* Use of antimitotic or antimetabolite therapy within 30 days or 5 elimination half-lives of the screening visit\n* Pregnant or breastfeeding, or intention to become pregnant during the study\n* Women of childbearing potential, must have a negative urine pregnancy test result within 28 days prior to initiation of study treatment. If the urine pregnancy test is positive, it must be confirmed by a serum pregnancy test.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "50 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Reference Study ID Number: ML43000 https://forpatients.roche.com/",
                    "role": "CONTACT",
                    "phone": "888-662-6728 (U.S.)",
                    "email": "global-roche-genentech-trials@gene.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Trials",
                    "affiliation": "Genetech",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Barnet Dulaney Perkins Eye Center",
                    "status": "RECRUITING",
                    "city": "Mesa",
                    "state": "Arizona",
                    "zip": "85206",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.42227,
                        "lon": -111.82264
                    }
                },
                {
                    "facility": "California Retina Consultants",
                    "status": "RECRUITING",
                    "city": "Bakersfield",
                    "state": "California",
                    "zip": "93309",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.37329,
                        "lon": -119.01871
                    }
                },
                {
                    "facility": "California Eye Specialists Medical group Inc.",
                    "status": "RECRUITING",
                    "city": "Pasadena",
                    "state": "California",
                    "zip": "91107",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.14778,
                        "lon": -118.14452
                    }
                },
                {
                    "facility": "Retinal Consultants Med Group",
                    "status": "RECRUITING",
                    "city": "Sacramento",
                    "state": "California",
                    "zip": "95825",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.58157,
                        "lon": -121.4944
                    }
                },
                {
                    "facility": "Orange County Retina Med Group",
                    "status": "RECRUITING",
                    "city": "Santa Ana",
                    "state": "California",
                    "zip": "92705",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.74557,
                        "lon": -117.86783
                    }
                },
                {
                    "facility": "Southwest Retina Consultants",
                    "status": "RECRUITING",
                    "city": "Durango",
                    "state": "Colorado",
                    "zip": "81303",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.27528,
                        "lon": -107.88007
                    }
                },
                {
                    "facility": "Retina Group of New England",
                    "status": "WITHDRAWN",
                    "city": "Waterford",
                    "state": "Connecticut",
                    "zip": "06385",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.3417,
                        "lon": -72.13597
                    }
                },
                {
                    "facility": "Ft Lauderdale Eye Institute",
                    "status": "WITHDRAWN",
                    "city": "Miami Lakes",
                    "state": "Florida",
                    "zip": "33016",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.90871,
                        "lon": -80.30866
                    }
                },
                {
                    "facility": "Retina Specialty Institute",
                    "status": "RECRUITING",
                    "city": "Pensacola",
                    "state": "Florida",
                    "zip": "32503",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.42131,
                        "lon": -87.21691
                    }
                },
                {
                    "facility": "Retina Vitreous Associates of Florida",
                    "status": "RECRUITING",
                    "city": "Saint Petersburg",
                    "state": "Florida",
                    "zip": "33711-1141",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.77086,
                        "lon": -82.67927
                    }
                },
                {
                    "facility": "Southeast Retina Center",
                    "status": "RECRUITING",
                    "city": "Augusta",
                    "state": "Georgia",
                    "zip": "30909",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.47097,
                        "lon": -81.97484
                    }
                },
                {
                    "facility": "University Retina and Macula Associates, PC",
                    "status": "RECRUITING",
                    "city": "Oak Forest",
                    "state": "Illinois",
                    "zip": "60452",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.60281,
                        "lon": -87.74394
                    }
                },
                {
                    "facility": "Wolfe Eye Clinic",
                    "status": "RECRUITING",
                    "city": "West Des Moines",
                    "state": "Iowa",
                    "zip": "50266",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.57721,
                        "lon": -93.71133
                    }
                },
                {
                    "facility": "Retina Associates of Kentucky",
                    "status": "RECRUITING",
                    "city": "Lexington",
                    "state": "Kentucky",
                    "zip": "40509",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.98869,
                        "lon": -84.47772
                    }
                },
                {
                    "facility": "The Retina Care Center",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21209",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Wilmer Eye Institute Johns Hopkins University",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21287-0005",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Retina Group of Washington",
                    "status": "WITHDRAWN",
                    "city": "Chevy Chase",
                    "state": "Maryland",
                    "zip": "20815",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.00287,
                        "lon": -77.07115
                    }
                },
                {
                    "facility": "Cumberland Valley Retina Consultants",
                    "status": "RECRUITING",
                    "city": "Hagerstown",
                    "state": "Maryland",
                    "zip": "21740-5940",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.64176,
                        "lon": -77.71999
                    }
                },
                {
                    "facility": "Associated Retinal Consultants PC",
                    "status": "RECRUITING",
                    "city": "Royal Oak",
                    "state": "Michigan",
                    "zip": "48073",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.48948,
                        "lon": -83.14465
                    }
                },
                {
                    "facility": "VitreoRetinal Surgery, PLLC.; DBA Retina Consultants of Minnesota",
                    "status": "RECRUITING",
                    "city": "Edina",
                    "state": "Minnesota",
                    "zip": "55435",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 44.88969,
                        "lon": -93.34995
                    }
                },
                {
                    "facility": "Midwest Vision Research Foundation",
                    "status": "RECRUITING",
                    "city": "Chesterfield",
                    "state": "Missouri",
                    "zip": "63017",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.66311,
                        "lon": -90.57707
                    }
                },
                {
                    "facility": "Sierra Eye Associates",
                    "status": "RECRUITING",
                    "city": "Reno",
                    "state": "Nevada",
                    "zip": "89502",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.52963,
                        "lon": -119.8138
                    }
                },
                {
                    "facility": "Mid Atlantic Retina",
                    "status": "WITHDRAWN",
                    "city": "Cherry Hill",
                    "state": "New Jersey",
                    "zip": "08034",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.93484,
                        "lon": -75.03073
                    }
                },
                {
                    "facility": "Western Carolina Retinal Associate PA",
                    "status": "WITHDRAWN",
                    "city": "Asheville",
                    "state": "North Carolina",
                    "zip": "28803",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.60095,
                        "lon": -82.55402
                    }
                },
                {
                    "facility": "Cincinnati Eye Institute",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45242",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Palmetto Retina Center, LLC",
                    "status": "WITHDRAWN",
                    "city": "West Columbia",
                    "state": "South Carolina",
                    "zip": "29169",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.99349,
                        "lon": -81.07398
                    }
                },
                {
                    "facility": "Palmetto Retina Center",
                    "status": "WITHDRAWN",
                    "city": "West Columbia",
                    "state": "South Carolina",
                    "zip": "29169",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.99349,
                        "lon": -81.07398
                    }
                },
                {
                    "facility": "Tennessee Retina PC",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "Austin Retina Associates",
                    "status": "RECRUITING",
                    "city": "Austin",
                    "state": "Texas",
                    "zip": "78705-1169",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.26715,
                        "lon": -97.74306
                    }
                },
                {
                    "facility": "Retina Consultants of Texas",
                    "status": "RECRUITING",
                    "city": "The Woodlands",
                    "state": "Texas",
                    "zip": "77384-4167",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.15799,
                        "lon": -95.48938
                    }
                },
                {
                    "facility": "Retina Associates of Utah, PLLC",
                    "status": "RECRUITING",
                    "city": "Salt Lake City",
                    "state": "Utah",
                    "zip": "84107",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.76078,
                        "lon": -111.89105
                    }
                },
                {
                    "facility": "Piedmont Eye Center",
                    "status": "RECRUITING",
                    "city": "Lynchburg",
                    "state": "Virginia",
                    "zip": "24502",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.41375,
                        "lon": -79.14225
                    }
                },
                {
                    "facility": "Wagner Kapoor Institute",
                    "status": "RECRUITING",
                    "city": "Norfolk",
                    "state": "Virginia",
                    "zip": "23502",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.84681,
                        "lon": -76.28522
                    }
                },
                {
                    "facility": "Retina Institute of Virginia",
                    "status": "WITHDRAWN",
                    "city": "Richmond",
                    "state": "Virginia",
                    "zip": "23235",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.55376,
                        "lon": -77.46026
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008268",
                    "term": "Macular Degeneration"
                },
                {
                    "id": "D000057135",
                    "term": "Wet Macular Degeneration"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012162",
                    "term": "Retinal Degeneration"
                },
                {
                    "id": "D000012164",
                    "term": "Retinal Diseases"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11260",
                    "name": "Macular Degeneration",
                    "asFound": "Age-related Macular Degeneration",
                    "relevance": "HIGH"
                },
                {
                    "id": "M28735",
                    "name": "Wet Macular Degeneration",
                    "asFound": "Neovascular Age-related Macular Degeneration",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14997",
                    "name": "Retinal Degeneration",
                    "relevance": "LOW"
                },
                {
                    "id": "M14999",
                    "name": "Retinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000069579",
                    "term": "Ranibizumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020533",
                    "term": "Angiogenesis Inhibitors"
                },
                {
                    "id": "D000043924",
                    "term": "Angiogenesis Modulating Agents"
                },
                {
                    "id": "D000006133",
                    "term": "Growth Substances"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000006131",
                    "term": "Growth Inhibitors"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M472",
                    "name": "Ranibizumab",
                    "asFound": "Subcutaneous injection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22318",
                    "name": "Angiogenesis Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M9231",
                    "name": "Growth Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}